Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410977090> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2410977090 endingPage "43" @default.
- W2410977090 startingPage "337" @default.
- W2410977090 abstract "The antitumor effect of docetaxel against cultured human esophagus tumor cell lines and tumor xenografts in nude mice was investigated. In the in vitro study, docetaxel showed concentration-dependent inhibition of the growth of 4 tumor cell lines having different degrees of differentiation (T. T, TE-5, TE-9 and TE-15) with IC(50) values ranging from 0.84 to 1.68 ng/ml when exposed for 72 h. These values represent ca. 1/2,700-1/1,400 of the mean maximum plasma concentration of 2.27 microg/ml attained in the clinical setting. In addition, the activity was found to be ca. two-fold stronger than that of paclitaxel, and much more potent than fluorouracil and cisplatin. The in vivo antitumor effect of docetaxel was also investigated against xenografts of human esophagus squamous cell carcinoma H-190 (highly differentiated) and H-204 (moderately differentiated) in nude mice. Docetaxel at its Maximum Tolerated Dose (MTD) and the lower dose (4.5, 6.7 mg/kg/dose, q 4 d x 3, iv) showed a significant growth inhibition of ca. 100% against H-190 tumor, resulting in the tumor shrinkage. Paclitaxel (6.7, 10 mg/kg/dose, q 4 d x 3, iv) showed a tumor-shrinking effect similar to that seen with docetaxel. In the H-204 xenograft model, docetaxel (4.5, 6.7, 10 mg/kg/dose) exhibited a dose-dependent effect in delaying the tumor growth, while paclitaxel failed to suppress the tumor growth even at its MTD. These results demonstrated that docetaxel has potent antitumor efficacy against human esophagus tumor cells, leading to the expectation that it will be useful as a therapeutic agent for esophagus cancer." @default.
- W2410977090 created "2016-06-24" @default.
- W2410977090 creator A5000142292 @default.
- W2410977090 creator A5008935559 @default.
- W2410977090 creator A5080607846 @default.
- W2410977090 date "2006-03-01" @default.
- W2410977090 modified "2023-09-23" @default.
- W2410977090 title "[Antitumor effect of docetaxel against human esophagus tumor cell lines and tumor xenografts in nude mice]." @default.
- W2410977090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16531714" @default.
- W2410977090 hasPublicationYear "2006" @default.
- W2410977090 type Work @default.
- W2410977090 sameAs 2410977090 @default.
- W2410977090 citedByCount "2" @default.
- W2410977090 countsByYear W24109770902015 @default.
- W2410977090 countsByYear W24109770902020 @default.
- W2410977090 crossrefType "journal-article" @default.
- W2410977090 hasAuthorship W2410977090A5000142292 @default.
- W2410977090 hasAuthorship W2410977090A5008935559 @default.
- W2410977090 hasAuthorship W2410977090A5080607846 @default.
- W2410977090 hasConcept C126322002 @default.
- W2410977090 hasConcept C150903083 @default.
- W2410977090 hasConcept C185592680 @default.
- W2410977090 hasConcept C202751555 @default.
- W2410977090 hasConcept C207001950 @default.
- W2410977090 hasConcept C2776694085 @default.
- W2410977090 hasConcept C2777292972 @default.
- W2410977090 hasConcept C2777819096 @default.
- W2410977090 hasConcept C2778239845 @default.
- W2410977090 hasConcept C2779707156 @default.
- W2410977090 hasConcept C2781190966 @default.
- W2410977090 hasConcept C502942594 @default.
- W2410977090 hasConcept C55493867 @default.
- W2410977090 hasConcept C71924100 @default.
- W2410977090 hasConcept C86803240 @default.
- W2410977090 hasConceptScore W2410977090C126322002 @default.
- W2410977090 hasConceptScore W2410977090C150903083 @default.
- W2410977090 hasConceptScore W2410977090C185592680 @default.
- W2410977090 hasConceptScore W2410977090C202751555 @default.
- W2410977090 hasConceptScore W2410977090C207001950 @default.
- W2410977090 hasConceptScore W2410977090C2776694085 @default.
- W2410977090 hasConceptScore W2410977090C2777292972 @default.
- W2410977090 hasConceptScore W2410977090C2777819096 @default.
- W2410977090 hasConceptScore W2410977090C2778239845 @default.
- W2410977090 hasConceptScore W2410977090C2779707156 @default.
- W2410977090 hasConceptScore W2410977090C2781190966 @default.
- W2410977090 hasConceptScore W2410977090C502942594 @default.
- W2410977090 hasConceptScore W2410977090C55493867 @default.
- W2410977090 hasConceptScore W2410977090C71924100 @default.
- W2410977090 hasConceptScore W2410977090C86803240 @default.
- W2410977090 hasIssue "3" @default.
- W2410977090 hasLocation W24109770901 @default.
- W2410977090 hasOpenAccess W2410977090 @default.
- W2410977090 hasPrimaryLocation W24109770901 @default.
- W2410977090 hasRelatedWork W1969739293 @default.
- W2410977090 hasRelatedWork W1986509532 @default.
- W2410977090 hasRelatedWork W2001476667 @default.
- W2410977090 hasRelatedWork W2003075460 @default.
- W2410977090 hasRelatedWork W2056944532 @default.
- W2410977090 hasRelatedWork W2094864265 @default.
- W2410977090 hasRelatedWork W2140814172 @default.
- W2410977090 hasRelatedWork W2256918946 @default.
- W2410977090 hasRelatedWork W2324594876 @default.
- W2410977090 hasRelatedWork W2348294335 @default.
- W2410977090 hasRelatedWork W2350100597 @default.
- W2410977090 hasRelatedWork W2361749309 @default.
- W2410977090 hasRelatedWork W2380237398 @default.
- W2410977090 hasRelatedWork W2391095549 @default.
- W2410977090 hasRelatedWork W2394477328 @default.
- W2410977090 hasRelatedWork W2428434333 @default.
- W2410977090 hasRelatedWork W2560538212 @default.
- W2410977090 hasRelatedWork W2953766479 @default.
- W2410977090 hasRelatedWork W66581159 @default.
- W2410977090 hasRelatedWork W2186867915 @default.
- W2410977090 hasVolume "33" @default.
- W2410977090 isParatext "false" @default.
- W2410977090 isRetracted "false" @default.
- W2410977090 magId "2410977090" @default.
- W2410977090 workType "article" @default.